• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新系统,老问题:高优先级移植候选人等待时间增加。

New system, old problem: Increased wait time for high-priority transplant candidates.

机构信息

Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.

Division of Cardiac, Thoracic, and Vascular Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, New York.

出版信息

J Heart Lung Transplant. 2023 Nov;42(11):1497-1500. doi: 10.1016/j.healun.2023.07.012. Epub 2023 Jul 26.

DOI:10.1016/j.healun.2023.07.012
PMID:37506955
Abstract

The 2018 heart allocation policy sought to improve risk stratification and reduce waitlist mortality for the sickest patients. This study sought to evaluate changes in wait times for the highest priority patients since policy implementation. All adult single-organ transplant recipients were identified in the United Network for Organ Sharing registry from October 18, 2018, to July 8, 2022, and separated into 4 periods. Outcomes were compared by blood type and UNOS region. Over the study period, 897 of 9,143 patients were listed as status 1 with no significant change in median wait time by blood type or region. More patients were listed as status 2 (4,523/9,143), and each subsequent period postpolicy change was associated with a 4.2-day increase in mean status 2 waitlist time (95% confidence interval 3.0-5.5, p < 0.0001). Wait times were longest for candidates with blood type O and shortest for AB & A. Regional variations continued, however, wait time increased in every region over time.

摘要

2018 年心脏分配政策旨在改善风险分层并降低病情最严重患者的候补名单死亡率。本研究旨在评估自政策实施以来,优先级最高患者的候补时间变化。自 2018 年 10 月 18 日至 2022 年 7 月 8 日,从美国器官共享网络登记处确定了所有成年单器官移植受者,并将其分为 4 个时期。通过血型和 UNOS 区域比较结果。在研究期间,9143 名患者中有 897 名列为 1 级,血型或区域对中位候补时间无明显变化。更多的患者被列为 2 级(4523/9143),政策变更后每个后续时期的平均 2 级候补名单时间增加了 4.2 天(95%置信区间 3.0-5.5,p<0.0001)。O 型血患者的候补时间最长,AB 和 A 型血患者的候补时间最短。然而,区域差异仍在继续,随着时间的推移,每个区域的候补时间都在增加。

相似文献

1
New system, old problem: Increased wait time for high-priority transplant candidates.新系统,老问题:高优先级移植候选人等待时间增加。
J Heart Lung Transplant. 2023 Nov;42(11):1497-1500. doi: 10.1016/j.healun.2023.07.012. Epub 2023 Jul 26.
2
Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm.2006年器官共享联合网络(United Network for Organ Sharing)对供体心脏分配算法进行政策调整后,受者等待名单时间以及移植前后死亡率的地区差异。
JACC Heart Fail. 2014 Apr;2(2):166-77. doi: 10.1016/j.jchf.2013.11.005.
3
Evolving Trends in Adult Heart Transplant With the 2018 Heart Allocation Policy Change.2018 年心脏分配政策变化后成人心脏移植的发展趋势。
JAMA Cardiol. 2021 Feb 1;6(2):159-167. doi: 10.1001/jamacardio.2020.4909.
4
Survival on the Heart Transplant Waiting List.心脏移植等待名单上的存活率。
JAMA Cardiol. 2020 Nov 1;5(11):1227-1235. doi: 10.1001/jamacardio.2020.2795.
5
Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts.美国扩大区域性供心共享后,心脏移植候补者死亡率下降。
Circ Heart Fail. 2012 Mar 1;5(2):249-58. doi: 10.1161/CIRCHEARTFAILURE.111.964247. Epub 2012 Jan 13.
6
Three-Year Left Ventricular Assist Device Outcomes and Strategy After Heart Transplant Allocation Score Change.心脏移植分配评分改变后三年左心室辅助装置的结果和策略。
Am J Cardiol. 2024 Sep 1;226:1-8. doi: 10.1016/j.amjcard.2024.07.001. Epub 2024 Jul 6.
7
Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.新的器官共享联合网络分配系统中 2 级状态患者等待时间的增加:对等候名单和移植后结果的影响。
J Thorac Cardiovasc Surg. 2024 Feb;167(2):535-543.e3. doi: 10.1016/j.jtcvs.2023.05.040. Epub 2023 Jun 16.
8
Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist.美国心脏移植候补患者中器官提供接受率和死亡率的移植中心变异性。
JAMA Cardiol. 2020 Jun 1;5(6):660-668. doi: 10.1001/jamacardio.2020.0659.
9
Impact of the 2018 UNOS Heart Transplant Policy Changes on Patient Outcomes.2018 年 UNOS 心脏移植政策变化对患者结局的影响。
JACC Heart Fail. 2023 May;11(5):491-503. doi: 10.1016/j.jchf.2023.01.009. Epub 2023 Mar 1.
10
The modified US heart allocation system improves transplant rates and decreases status upgrade utilization for patients with hypertrophic cardiomyopathy.改良后的美国心脏分配系统提高了肥厚型心肌病患者的移植率,并减少了其升级利用状态。
J Heart Lung Transplant. 2021 Oct;40(10):1181-1190. doi: 10.1016/j.healun.2021.06.018. Epub 2021 Jul 10.

引用本文的文献

1
Does temporary mechanical circulatory support with Impella 5.5 induce de novo human leukocyte antigen antibodies production in heart transplantation candidates?使用Impella 5.5进行临时机械循环支持是否会诱导心脏移植候选者产生新的人类白细胞抗原抗体?
JHLT Open. 2024 Feb 16;4:100072. doi: 10.1016/j.jhlto.2024.100072. eCollection 2024 May.